Akorn, Inc. is a pharmaceutical company with its main headquarters located in Lake Forest, Illinois, alongside various manufacturing and operational facilities.
Subscribe to see Akorn’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Akorn is a pharmaceuticals company headquartered in United States. Its most recent funding round, Grant, closed in September 2025.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | Undisclosed | — | |
| Grant | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Akorn's closest competitors — see the full list of competitors and alternatives →
Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing, and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis operates in approximately 100 countries and has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey.
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
Harrow Health, Inc. is a specialty pharmaceutical company focused on ophthalmic products, including FDA-approved and compounded medications used in eye care. It serves ophthalmologists, other eye-care professionals, and patients requiring treatments for conditions and procedures involving the eye.
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company with its global headquarters located in Tel Aviv, Israel, dedicated to delivering quality medications.
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.
SK-Pharma is a global pharmaceutical company and supplier of medications, specializing in early generics, rare drugs, value-added generics, and specialty products such as orphan drugs and complex generics. The company focuses on improving drug accessibility, market monitoring, and supply chain optimization to serve patients worldwide.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.